R Adam Smith - JoVE Visualize

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

BMJ Open Respiratory Research|December 31, 2021

Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD)Tamera J Corte, Lisa Lancaster, Jeffrey J Swigris, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 14, 2017

Synthesis and Biologic Evaluation of a Novel 18F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 ExpressionDavid J Donnelly, R Adam Smith, Paul Morin, et al.

Cancer Discovery|November 4, 2011

ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancerTodd W Miller, Justin M Balko, Emily M Fox, et al.

Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

BMJ Open Respiratory Research|December 31, 2021

Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD)Tamera J Corte, Lisa Lancaster, Jeffrey J Swigris, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 14, 2017

Synthesis and Biologic Evaluation of a Novel 18F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 ExpressionDavid J Donnelly, R Adam Smith, Paul Morin, et al.

Cancer Discovery|November 4, 2011

ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancerTodd W Miller, Justin M Balko, Emily M Fox, et al.

Pageof 2